With the past 40 years of point-of-care excellence to share, ITC is a worldwide leader in the fields of coagulation management and point-of-care testing. Through internal development, strategic partnerships and alliances, ITC is committed to delivering the safest, easiest to use, and most reliable product and customer service. Our employees, clinicians and patients understand that ITC's products are designed to deliver patients the best available healthcare.

ITC is actively looking for partners to work with for developing new point-of-care test systems for alternate site and hospital distribution. We are interested in strategic partnerships, alliances, and investing in companies that will address these segments of healthcare. If your organization is working with or you know of companies that are involved in these areas of healthcare, that are interested in forming a strategic partnership, licensing of their technology, co-marketing, etc., we would appreciate hearing from you. ITC point-of-care technology is the monitoring instrument of choice for pharmaceutical drug clinical trials in the cardiovascular arena. We offer biomedical and engineering research and development capabilities, as well as state of the art manufacturing facilities. We have the ability to custom manufacture private labeled point-of-care coagulation systems based on our technologies.

If you have an interest in or would like more information about partnering with ITC, please contact us at:

ITC Business Development
8 Olsen Ave.
Edison, NJ 08820
(732) 548-5700 x300
businessdevelop@itcmed.com